AKAO Abuzz, AAAP Gets FDA Blessing, CORT Under Close Watch, Big Day For MBRX

Shares of Achaogen Inc. (AKAO) rose nearly 13% on Thursday, following a $20 million contract option awarded by BARDA to support the development of the company's lead product candidate Plazomicin.

from RTT - Biotech http://ift.tt/1Pp7For
via IFTTT